These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 14611859

  • 1. Two antiviral compounds from the plant Stylogne cauliflora as inhibitors of HCV NS3 protease.
    Hegde VR, Pu H, Patel M, Das PR, Butkiewicz N, Arreaza G, Gullo VP, Chan TM.
    Bioorg Med Chem Lett; 2003 Sep 01; 13(17):2925-8. PubMed ID: 14611859
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Screening of antiviral activities in medicinal plants extracts against dengue virus using dengue NS2B-NS3 protease assay.
    Rothan HA, Zulqarnain M, Ammar YA, Tan EC, Rahman NA, Yusof R.
    Trop Biomed; 2014 Jun 01; 31(2):286-96. PubMed ID: 25134897
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
    Stoermer MJ, Chappell KJ, Liebscher S, Jensen CM, Gan CH, Gupta PK, Xu WJ, Young PR, Fairlie DP.
    J Med Chem; 2008 Sep 25; 51(18):5714-21. PubMed ID: 18729351
    [Abstract] [Full Text] [Related]

  • 8. A review of HCV protease inhibitors.
    Chen KX, Njoroge FG.
    Curr Opin Investig Drugs; 2009 Aug 25; 10(8):821-37. PubMed ID: 19649927
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
    Dwivedi VD, Tripathi IP, Mishra SK.
    J Vector Borne Dis; 2016 Aug 25; 53(2):156-61. PubMed ID: 27353586
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3/P4 urea leads to potent intracellular inhibitors of hepatitis C virus NS3/4A protease.
    Slater MJ, Amphlett EM, Andrews DM, Bamborough P, Carey SJ, Johnson MR, Jones PS, Mills G, Parry NR, Somers DO, Stewart AJ, Skarzynski T.
    Org Lett; 2003 Nov 27; 5(24):4627-30. PubMed ID: 14627400
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis of BILN 2061, an HCV NS3 protease inhibitor with proven antiviral effect in humans.
    Faucher AM, Bailey MD, Beaulieu PL, Brochu C, Duceppe JS, Ferland JM, Ghiro E, Gorys V, Halmos T, Kawai SH, Poirier M, Simoneau B, Tsantrizos YS, Llinàs-Brunet M.
    Org Lett; 2004 Aug 19; 6(17):2901-4. PubMed ID: 15330643
    [Abstract] [Full Text] [Related]

  • 19. Structure-based drug design of novel peptidomimetic cellulose derivatives as HCV-NS3 protease inhibitors.
    Saleh NA, Elshemey WM.
    Life Sci; 2017 Oct 15; 187():58-63. PubMed ID: 28842311
    [Abstract] [Full Text] [Related]

  • 20. Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection.
    Tsantrizos YS, Bolger G, Bonneau P, Cameron DR, Goudreau N, Kukolj G, LaPlante SR, Llinàs-Brunet M, Nar H, Lamarre D.
    Angew Chem Int Ed Engl; 2003 Mar 28; 42(12):1356-60. PubMed ID: 12671967
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.